Skip Navigation

Sharing Knowledge.

Supporting People.

Advancing Care.

About the Bronchiectasis and NTM Association

The Bronchiectasis and NTM Association is dedicated to improving the lives of people affected by bronchiectasis and NTM lung disease. The Association is committed to advancing high-quality, specialized care, research, education, support, and advocacy within the bronchiectasis and NTM lung disease communities, helping people live longer, healthier lives.

Latest Activity

Read the latest activity from our blog, press releases and BronchandNTM360social, our online community.

Latest Blog Post

Blog

What Is the Bronchiectasis and NTM Care Center Network?

This blog post was authored by Lucinda Shore and reviewed by the Bronchiectasis and NTM Content Review and Evaluation Committee.As bronchiectasis and nontuberculous mycobacterial (NTM) lung disease become more common in the U.S., getting a quick, accurate diagnosis and expert care is very important. To help meet this need, the Bronchiectasis and NTM Association created the Bronchiectasis and NTM Care Center Network (CCN).The CCN connects people to medical centers throughout the U.S. that provide expert care and treatment, high-quality education, advice, and support for those living with bronchiectasis and NTM lung disease. The CCN gives sites one of two designations:Care Center: These centers offer a clinical research program, treat hundreds of people with bronchiectasis and NTM, and provide direct access to specialists (like dietitians or psychologists) for immediate care.Clinical Associate Center (CAC): CACs provide high-quality, expert care, but may see fewer people with both conditions, may be less involved in research, and may not have access to specialists within the center.

Read More
Abstracts

Press Release

Bronchiectasis and NTM Association announces Externally-Led Patient-Focused Drug Development meeting for non-cystic fibrosis bronchiectasis

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This meeting is modeled after the Food & Drug Administration’s (FDA) PFDD public meetings. Drug developers, FDA, and other stakeholders will be in attendance.NCFB is a chronic lung disease characterized by inflammation and chronic infection in which the airways become abnormally widened, thickened, and/or scarred. Once considered rare, NCFB is now recognized more widely as awareness, research, and advances in imaging have improved understanding of the disease. Although the first FDA-approved treatment for NCFB became available in 2025, significant challenges remain. Many people still face delays in diagnosis, limited access to specialized care, and difficulties managing the disease’s daily impact.The NCFB EL-PFDD meeting will:Enhance understanding of how living with NCFB impacts daily life experiences;Capture diverse perspectives of the NCFB community to help foster timely and effective therapy development; andInform regulatory decision-making with insights on current care and treatment benefit needs.

Read More
360Social

Discussion

When Should a BNTM Patient See an Immunologist

WHEN SHOULD A BNTM PATIENT SEE AN IMMUNOLOGIST?An immunologist specializes in identifying and treating disorders of the immune system. For some BNTM patients, an evaluation may provide important answers.🔎 When might a referral to an immunologist be helpful? Consider asking your pulmonologist about an immunology evaluation if you experience:🔹 Frequent respiratory infections – Repeated bronchitis, pneumonia, sinus infections, or other respiratory illnesses.🔹 Recurrent NTM infections – Especially when infections persist, recur, or are difficult to manage.🔹 Low immunoglobulin levels – Abnormal IgG, IgA, or IgM levels may suggest an underlying immune deficiency.  Immunoglobulins are proteins, also called antibodies, produced by immune cells (plasma cells) to help your body defend against infections and other threats 🔹 Poor vaccine responses – Your body may not be producing adequate protective antibodies after certain vaccinations.🔹 Unusual or persistent infections – Infections that are more frequent, severe, or difficult to treat than expected.🔹 A family history of immune disorders – Certain immune deficiencies can run in families.🧪 What might an immunologist evaluate? Depending on your history, testing may include:Immunoglobulin levels (IgG, IgA, IgM).Specific antibody responses to vaccines.White blood cell and lymphocyte counts.Evaluation for primary or secondary immune deficiencies.WHY DOES THIS MATTER? Some patients with bronchiectasis and NTM may have an underlying immune system problem that contributes to their susceptibility to infections.  Identifying an immune deficiency may help guide additional treatment, preventive strategies, and coordination of care.YOUR CARE TEAM MATTERS! Your pulmonologist and infectious disease specialist are important members of your BNTM care team. An immunologist may provide another valuable perspective when recurrent infections or suspected immune deficiencies are part of your story.  Do not assume that repeated lung infections are simply part of living with BNTM. Ask whether an evaluation of your immune system makes sense.Advocate. Ask questions. Be proactive.

Read More

New Bronchiectasis Diagnoses

Approximately 70,000 adults are newly diagnosed with bronchiectasis each year in the United States. An estimated 350,000 to 500,000 adults in the U.S. currently living with the condition.

8,600+

Bronchiectasis and NTM Research Registry

The Registry connects people with research to advance care. Participants help support clinical trials and accelerate the development of new treatments.

5,100+

BronchandNTM360social Membership

Join our growing online community to find support, ask questions and connect with others.

Monthly giving is an easy and impactful

Make an Impact

Help us move our mission forward and expand trusted education, strengthen advocacy, advance research, and improve care and resources for patients, families, caregivers, and providers.

World Bronchiectasis Day

World Bronchiectasis Day

Observed annually on July 1, World Bronchiectasis Day is a global campaign designed to raise awareness of bronchiectasis.

Stay In Touch

Sign up for our newsletter for information on upcoming events, virtual meetups, new research, treatment tips, and more, delivered straight to your inbox.